Because of You Campaign
Showing of 45 results
A Legacy of Giving and Vision: Dee Kleinman Strengthens Eye Care at UH
For nearly 50 years, Dee Kleinman has supported UH in countless ways, as both a volunteer and a philanthropist. In recognition of her exceptional treatment, she made a gift to establish the James & Dolores Kleinman Chair in Ophthalmology.
Grateful Family Gives Back to UH Rainbow
In 2023, Nash Finkler hit his head in a fall. He was rushed to UH Rainbow Babies & Children’s, where he was treated for a blood clot in the brain. Today, Nash is doing well. In recognition of his care, his family made a donation to UH Rainbow’s PICU.
Scalp Cooling Helps Reduce Hair Loss During Chemo
Scalp cooling therapy is a process that can help reduce hair loss caused by certain chemotherapy drugs. It uses a specially fitted cap worn before, during and after chemo.
UH TriPoint Medical Center Expands Breast Care Services with Opening of New Breast Center
UH is bringing transformative breast care to UH TriPoint Medical Center with a new breast center. UH TriPoint Breast Center elevates care by unifying breast health services in one convenient location to enhance the patient experience.
UH Leading the Way in AI-Assisted Healthcare
Artificial intelligence (AI), the transformative data-driven technology that emulates human brain power, is revolutionizing the healthcare landscape.
Roe Green Scholar Creates Surgical Teaching App
Rachel Pope, MD, MPH, an obstetrician/gynecologist at the UH Urology Institute and a UH Roe Green Global Health Scholar, is fellowship-trained in global women’s health. She recently developed an app to help train more physicians in fistula repairs.
Groundbreaking Study Shows Alzheimer’s Disease Can Be Reversed in Animal Models
A new study led by UH’s Andrew Pieper, MD, PhD and his team is changing how we think about Alzheimer’s disease. The team has confirmed in animal models that restoring the brain’s energy balance not only stops the disease, but also reverses damage.
Breakthrough Heart Attack Treatment Moves into Clinical Trials
A promising new medicine for heart attack patients has reached a major milestone: successful results in a pivotal Phase 3 clinical trial. Support from Harrington Discovery Institute at University Hospitals helped make the achievement possible.